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Abstract
Aminoacyl-tRNA synthetases (ARSs) are critical components of protein translation, providing ribosomes with aminoacyl-
tRNAs. In return, ribosomes release uncharged tRNAs as ARS substrates. Here, we show that tRNA deacylation can be
uncoupled from protein synthesis in an amino acid specific manner. While tRNAs coupled to radiolabeled Met, Leu Lys, or
Ser are stable in cells following translation inhibition with arsenite, radiolabeled Cys is released from tRNA at a high rate. We
discuss possible translation independent functions for tRNA
Cys.
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Introduction
Aminoacyl-tRNA synthetases (ARSs) catalyze the attachment of
the 20 canonical amino acids to their cognate tRNAs. Since
ribosomes poorly discriminate between amino acid homologs,
ARSs play an essential role in minimizing errors in amino acid
incorporation into proteins. Recent findings suggest that modifi-
cations in ARS specificity can alter decryption of the genetic code,
adding an unexpected twist to the function of these ancient
enzymes at the very center of cellular function [1,2].
ARSs can be classified by different means. Based on the
architecture of their catalytic site -thought to reflect the primordial
enzymes - they can be divided into two classes of 10 ARSs each [3]
including 6 subclasses total (grouping enzymes having the closest
relationship). Recently, we classified ARSs into 3 distinct groups,
based on their association with ribosomes [4]: ‘‘free’’ ARSs
(designated by their single letter amino acid code, ARS, CRS,
GRS, HRS, NRS, SRS, TRS, VRS, WRS, YRS), ARSs forming
the Multi-aminoacyl-tRNA Synthetase Complex (MSC: EPRS
(ERS and PRS are present in a single protein), DRS, IRS, KRS,
LRS, MRS, QRS, and RRS), and FRS. FRS tightly associates
with ribosomes regardless of translation activity, while the MSC
associates with polysomes, and the free ARSs loosely associate with
polysomes.
The translation-dependent association of ARSs with polysomes
builds on the work of Deutscher and colleagues indicating that
translation is a channeled process likely to be highly compart-
mentalized to enable mRNAs to be translated under optimal
conditions [5]. It is now clear that polysomes partition into
multiple intracellular locales. It is likely that the functions of ARSs
and tRNA species utilized are intricately regulated to increase the
efficiency of protein biogenesis.
Adding to the complexity, ARSs have a number of defined
alternative functions, hardly surprising for such ancient and
abundant (,10
7 copies/cell) proteins. Here we characterize the
functions of representative ARSs and their cognate tRNAs in cells
under normal and stressed conditions.
Results and Discussion
In the course of studying the phenomenon of MSC-mediated
Met-misacylation, we compared the properties of the two sulfur
amino acid ARSs, MRS and CRS, both members of the Ia ARS
subclass. While MRS and CRS exhibit a similar distribution
pattern by immunofluorescence, they demonstrate markedly
different detergent solubilities. CRS is readily released from cells
by mild detergent (digitonin), while ,90% of MRS is retained by
cells, possibly due to MSC association with ER-complexed
polysomes (Fig. 1A and 1B) [4,6].
In exploring the charging status of tRNA by pulse labeling cells
with [
35S]-Met or [
35S]-Cys following various perturbations, we
found a number of surprising differences in their behavior. First,
although the specific activities of the amino acids are similar
according to the supplier, [
35S]-Met is incorporated at ,10-fold
higher levels in tRNA after pulse labeling (Fig. 1D and 1E). Since
Met and Cys are similarly represented in proteins, this suggests a
fundamental difference in the contribution of extracellular vs.
intracellular pools for Met vs. Cys tRNA acylation.
Second, we treated cells with inhibitors that block protein
synthesis directly (pactamycin, which inhibits translation initiation
[7]), or indirectly by inducing stress with MG132 (which inhibits
proteasomes), or the oxidizing agent sodium arsenite [8]. These
treatments inhibited incorporation of Met and Cys into proteins in
parallel (Fig. 1C) (the small additional amount of Cys incorpora-
tion into proteins following translation inhibition is not due to
translation, but to post-translational association [9]). As expected
from the inhibition of protein synthesis, Met tRNA acylation was
greatly inhibited, which we attribute to the limited amount of
substrate (unconjugated Met-tRNA). By contrast, Cys acylation
continues unabated in cells with essentially no translation activity.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33072These findings were made by measuring radioactivity in tRNA
fractions (Fig. 1D). These data were correlated with tRNA isolated
in agarose gels, which provides somewhat less precision and
reproducibility than the direct counting method due to additional
processing steps (Fig. 1E).
We confirmed disparities that can occur in Met vs. Cys tRNA
acylation by measuring their on- and off-kinetics in control cells or
cells incubated with arsenite to inhibit translation. Met charging
was severely depressed, while Cys charging was remarkably
unaffected by translational status (Fig. 2A and 2B). Similarly, Met
discharging was minimal in arsenite treated cells while Cys
discharging was only slightly impeded by arsenite (Fig. 2C and
2D).
We extended these findings to 3 other radiolabeled amino acids:
[
3H]-Leu, [
3H]-Lys and [
3H]-Ser. LRS and KRS are MSC
components [10]. SRS, like CRS, is ‘‘free’’ in the cytosol [4]. The
deacylation of these 3 amino acids was inhibited by protein
synthesis inhibitors (Fig. 3A, 3B and 3C), underlining the
specificity of the deacylation mechanism observed for Cys-
tRNA
Cys.
Our findings differ somewhat from Aspen and Hoagland’s [11],
who also studied the kinetics of tRNA acylation/deacylation in
HeLa cells. Leu, Arg, and Ser (as well as Phe, Val, and Lys) were
all rapidly released from tRNA when protein synthesis was
inhibited by incubation at 15uCo ra t3 0 uC in the presence of the
chain elongation inhibitor cycloheximide (CHX). The extent to
which this is due to differences in temperatures used in the two
studies (all of our experiments were performed at 37uC) or
inhibitors used (cycloheximide vs. aresenite) remains to be
determined.
The differential behavior of extracellular [
35S]-labeled Met and
Cys tRNA acylation and incorporation into protein has an
immediate practical implication. When using Tran
35S-label
mixtures of Met and Cys to label cells, more than 95% of
translationally incorporated radiolabel should represent Met, since
Met is present at 5:1 in the mixture (according to the supplier), and
Figure 1. MRS and CRS define two distinct cytosolic compartments. A. Immunofluorescence staining of HeLa cells. MRS (green) and CRS (red)
only partially co-localize. Bar scale: 10 mm. B. Immunoblot of sequential HeLa cells extractions. Cells were first extracted with digitonin (DSC: digitonin
soluble compartment), then washed and extracted with NP-40 (DRC: digitonin resistant compartment). Membranes were blotted for MRS, CRS and
ribosomal P proteins. C. HeLa cells were pre-treated for 2 h with MG132 or for 30 min with either arsenite or pactamycin. Then cells were labeled with
[
35S]-Cys or [
35S]-Met. Half of each sample was used to extract total proteins and cpm were counted. 100% cpm was determined using untreated
HeLa cells. For [
35S]-Met: 100%=982785 cpm. For [
35S]-Cys: 100%=371828 cpm. D. The other half of each sample from ‘‘C’’ was used. Total RNAs
were extracted and cpm counted. 100% cpm was determined using untreated HeLa cells. For [
35S]-Met: 100%=288248 cpm. For [
35S]-Cys:
100%=69183 cpm. E. The same samples used in ‘‘D’’ were loaded on acid gels to visualize either [
35S]-Met-tRNAs or [
35S]-Cys-tRNAs. The two bands
for [
35S]-Met-tRNAs correspond to the mitochondrial tRNA
Met and the nuclear encoded tRNA
Met.
doi:10.1371/journal.pone.0033072.g001
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PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33072Figure 2. Cys-tRNA deacylation is uncoupled from translation. A. Kinetics of [
35S]-Met charging on tRNAs with or without pre-treating HeLa
cells with sodium arsenite. The same samples were both analyzed by beta counter and loaded on a native acid gel. B. Same as ‘‘A’’ with [
35S]-Cys
charging. C. Kinetics of [
35S]-Met deacylation on tRNAs extracted from HeLa cells pretreated or not with sodium arsenite. This panel shows two
different graph representations: ‘‘raw’’ data using Cpm/mg of total RNA and representing one experiment or calibrated data defining time 0 as 100%
of [
35S]-Met charged tRNAs and averaging 2 distinct experiments. The same samples were both analyzed by beta counter and loaded on native acid
gels. D. Same as ‘‘A’’ with [
35S]-Cys deacylation.
doi:10.1371/journal.pone.0033072.g002
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differential behavior of Met- vs. Cys-tRNA in the absence of
protein synthesis will confound analysis of off-kinetics, particularly
if one of the tRNAs is enriched following fractionation. This may
contribute to the differential behavior of ER vs. cytosol Tran
35S-
labelled- tRNA reported by Stephens et al. [12].
The mechanism underlying Cys-tRNA
Cys deacylation remains
to be established. One suspect is CRS, since ARSs are generally
capable of catalyzing deacylation [13,14]. Another candidate is
PDRX, the human homolog of the bacterial Ybak Cys-tRNA
Cys
deacylase, hypothesized to be involved in cell growth control [15].
We have been unable to amplify its mRNA in HeLa cells by PCR,
suggesting its absence in this cell line. Given the energy
dependence of tRNA acylation (one ATP-AMP conversion per
cycle), and the expense of synthesizing more CRS than absolutely
necessary for protein synthesis, it is likely that Cys deacylation
serves a function. Since a significant fraction of cellular Cys is
present in glutathione, it is possible that Cys deacylation is linked
in some manner to glutathione regulation. Acylated tRNAs are
known to participate in post-translational addition of amino acids
to proteins. Cys is not documented to modify proteins in this
manner, but a number of MHC bound peptides are cysteinylated,
consistent with this possibility [16,17]. On the other hand,
cysteinylation should be relatively infrequent, and not account
for the substantial off rate of Cys in the absence of translation, fully
half the delivery rate for protein synthesis. Staschke et al. [18]
reported that tRNA
Cys, along with several other tRNAs, are
deacylated in yeast in response to amino acid starvation, and
suggested a possible role for deacylated tRNA
Cys in regulating
cellular responses to nutritional status.
Research into protein translation has returned to the main stage
of cell biology, with progress driven by application of advances in
bioinformatics, microscopy, and mass spectrometry. This is timely,
as so many basic aspects of translation are poorly understood. It is
clear that protein synthesis is more complex than simple decoding.
Rather, translation is subtly regulated by mRNA structure, codon
usage, modulation of ARS specificity, and is organized spatially to
optimize interactions of nascent chains with chaperones and other
factors to facilitate protein folding and assembly. Our findings
underscore the many unknowns regarding the trafficking of tRNAs
in maximizing their efficiency in mediating translation and other
competing processes.
Materials and Methods
Cells and treaments
HeLa cells (ATCC) were cultured in DMEM (Invitrogen,
Carlsbad, CA) supplemented with 7.5% FBS (HyClone Labora-
tories, Logan, UT), at 37uC, 9% CO2. Cells were plated overnight
in T75 flasks to yield ,80% confluence at the start of the
experiment.
Drugs were used at the indicated concentrations and times:
MG132 (5 mM, 2 h, Sigma), pactamycin (0.5 mM, 30 min),
sodium arsenite (500 mM, 30 min, Sigma).
Figure 3. Leu-tRNA, Lys-tRNA and Ser-tRNA deacylation is coupled to translation. A. Kinetic of [
3H]-Leu deacylation on tRNAs extracted
from HeLa cells treated or not with sodium arsenite. B. Same as ‘‘A’’ with [
3H]-Lys deacylation. C. Same as ‘‘A’’ with [
3H]-Ser deacylation.
doi:10.1371/journal.pone.0033072.g003
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HeLa cells were extracted by a sequential detergent extraction
protocol based on previous studies [4,19]. Briefly, cell monolayers
were washed with PBS, and incubated with permeabilization
buffer (50 mM Tris-HCl pH 7.5, 5 mM MgCl2, 25 mM KCl,
100 mg/mL CHX, EDTA-free protease inhibitors (Roche), 10 U/
mL RNAse Out (Invitrogen)) containing 0.015% digitonin for
5 min on ice. The supernatant was recovered and cells were
washed once with permeabilization buffer. Permeabilized cell
monolayers were then solubilized with an equal volume of
permeabilization buffer containing 1% NP40 for 5 min on ice.
The supernatant (membrane-bound fraction) was recovered, and
both DSC and DRC were loaded on a SDS-PAGE gel.
Immunofluorescence and Microscopy
Immunofluorescence was performed using staining buffer
(0.05% saponin, 10 mM glycine, 5% FBS, PBS) as previously
described [4]. Following immunostaining procedure, cells were
labeled with Hoechst (Molecular Probes). Then, coverslips were
mounted with Fluoromount-G (SouthernBiotech). Images were
acquired with a Leica TCS SP5 confocal microscope (LAS AF
software) and HCX PLAPO 636 objective lenses (Numerical
aperture: 1.4). Images were processed with Adobe Photoshop
using only the levels and contrast adjustments.
Antibodies
Mouse anti-SRS and anti-MRS were purchased from Abnova.
Human anti-ribosomal P antiserum was from Immunovision.
Acylated tRNA extraction
,1610
7 HeLa cells per treatment were pulse-labeled with 1
mCi of [
35S]-Met or [
35S]-Cys or [
3H]-Leu or [
3H]-Lys or [
3H]-
Ser (Amersham or Perkin-Elmer) for 8 min (in a custom DMEM
lacking the corresponding amino-acid), washed and resuspended
in 500 ml of 300 mM sodium acetate pH4.8 (NaOAc/HOAc)/
10 mM EDTA. Acidic pH was chosen to stabilize the aminoacyl
linkage. Cells were transferred to tubes containing 1.4 mm
ceramic spheres (MP, Solon, OH) and 500 ml of NaOAc/HOAc
saturated phenol-chloroform (Perkin-Elmer) and 1% SDS, incu-
bated at 4uC for 30 min with vigorous shaking, and centrifuged at
13,000 rpm for 15 min at 4uC. RNA was precipitated from the
aqueous phase using an equal volume of isopropanol, washed with
70% ethanol/30% 50 mM NaOAc/HOAc pH4.8, dried and
resuspended in 10 mM NaOAc/HOAc pH4.8/1 mM EDTA.
For deacylation experiments, cells were pulse-labeled for 5 min,
washed twice with cold DMEM containing 7.5% FBS and
incubated for 2, 4, 6 and 8 minutes with warm DMEM containing
7.5% FBS.
Each sample was diluted in ‘‘Optiphase Supermix scintillation
liquid’’ (PerkinElmer) and cpm were counted using a b-counter
MicroBeta Trilux (PerkinElmer).
Prism software (GraphPad) was used for analysis and curve
fitting.
Radiolabeled protein extraction and cpm counting
,1610
7 HeLa cells per treatment were pulse-labeled the same
way as for tRNA extraction (they were done simultaneously with
HeLa cells used for total RNA extraction). Cells were washed
twice with cold PBS before being resuspended with 500 mL Lysis
Buffer (1% SDS, 150 mM NaCl, 50 mM Tris-HCl pH7.5)
supplemented with proteasome inhibitor tablet (Roche) and
MG132 (5 mM). Cell lysates were boiled for 20 min at 95uC
before being diluted in 1 mL of Neutralizing Buffer (1.5% NP-40,
150 mM NaCl, 50 mM Tris-HCl pH7.5). 2 mL of each sample
were applied per spot of 96 filter mat (averaging 6 replicates per
condition). After drying at 60uC, the mat was incubated in 10%
TCA for 30 min at RT, washed twice in 70% ethanol solution
(10 min/wash), dried at 60uC and placed in a scintillation bag with
5 mL of scintillation liquid (PerkinElmer). Radioactivity was
quantitated using a b-counter (1450 LSC Trilux, PerkinElmer).
Acid gel
Native acid gels were made based on a previously published
protocol [20]. Briefly, each gel was constituted by 10% acrylamide
(National Diagnostic), 7 M urea (Invitrogen) gel, 25 mM acetate
buffer, pH 4.8. Each gel was first pre-run in 100 mM tris-acetate
pH 4.8 for 1 h. For each condition, 2 mg of total RNA was loaded
and run at 4uC for ,5 h, Then, each gel was vacuum dried and
exposed to phosphorimaging plates (Fuji Medicals) for 16–24 h.
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